1. Phase I and Phase II Study Groups

Publisher： Karger

E-ISSN： 2296-5262|21|3|1-61

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.3, 1998-07, pp. : 1-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I/II Study of Preoperative Concurrent Chemoradiotherapy with S-1 for Locally Advanced, Resectable Rectal Adenocarcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2011-12 ,pp. : 306-311

Karger

Access to resources Recommend Favorite

Phase I/II Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC1 signal peptide vaccine, in multiple myeloma patients

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 1, 2015-04 ,pp. : 44-56

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Early Phase II Study of S-1 in Patients with Metastatic Pancreatic Cancer

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

A Phase I/II Study of Dose-Escalated Ifosfamide plus Carboplatin Combination for Advanced Ovarian Carcinoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 3, 1999-07 ,pp. : 212-215

Karger

Access to resources Recommend Favorite